IDXX
IDEXX Laboratories, Inc.
Large cap$42.9B
↓ 29%$544.32
PEG 3.5IDEXX Laboratories's profitability, revenue, and debt held up through a 29% drop from its 52-week high.
52-wk range
$518.55$769.98
Fundamentals holding up through the dip.
4 of 4 fundamentals trending the right way over the past few years.
- RevenueGrowing
- '22
- 3.4B
- '23
- 3.7B
- '24
- 3.9B
- '25
- 4.3B
- vs last qtr
- ↑4.6%
- IncomeGrowing
- '22
- 679M
- '23
- 845M
- '24
- 888M
- '25
- 1.1B
- vs last qtr
- ↑12.2%
- DebtDecreasing
- '22
- 1.5B
- '23
- 1.1B
- '24
- 987M
- '25
- 976M
- vs last qtr
- ↑13.3%
- MarginsImproving
- '22
- 20%
- '23
- 23%
- '24
- 23%
- '25
- 25%
- vs last qtr
- ↑1.7%
| '22 | '23 | '24 | '25 | vs last quarter | ||
|---|---|---|---|---|---|---|
| Revenue | Growing | 3.4B | 3.7B | 3.9B | 4.3B | ↑4.6% |
| Income | Growing | 679M | 845M | 888M | 1.1B | ↑12.2% |
| Debt | Decreasing | 1.5B | 1.1B | 987M | 976M | ↑13.3% |
| Margins | Improving | 20% | 23% | 23% | 25% | ↑1.7% |
Price history
- 30-day change: 1.9%
- 90-day change: 3.8%
- Down 29.3% from 52-week high
Key metrics
72.9%
71%
24.6%
14.3%
40.0x
30.9x
33.0x
3.49
$42.9B
A snapshot frozen at the time the July 26, 2026 scan ran. Not investment advice.